Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
Clinical trial NCT04109222 · COMPLETED
Trial details
- NCT number
- NCT04109222
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2019-12-10
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.